We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are three stocks with buy rank and strong income characteristics for investors to consider today, July 27th:
Libbey Inc. : This seller of tableware products has witnessed the Zacks Consensus Estimate for its current year earnings rising 2.8% over the last 60 days.
This Zacks Rank #2 (Buy) company has a dividend yield of 6.65%, compared with the industry average of 1.64%. Its five-year average dividend yield is 2.53%.
Kohl's Corporation (KSS - Free Report) : This omni-channel retailer has witnessed the Zacks Consensus Estimate for its current year earnings advancing 0.6% over the last 60 days.
This Zacks Rank #2 (Buy) company has a dividend yield of 3.31%, compared with the industry average of 0.47%. Its five-year average dividend yield is 3.7%.
Guess', Inc. (GES - Free Report) : This apparel company has witnessed the Zacks Consensus Estimate for its current year earnings rising 2% over the last 60 days.
This Zacks Rank #2 (Buy) company has a dividend yield of 3.94%, compared with the industry average of 0.00%. Its five-year average dividend yield is 4.8%.
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Top Ranked Income Stocks to Buy for July 27th
Here are three stocks with buy rank and strong income characteristics for investors to consider today, July 27th:
Libbey Inc. : This seller of tableware products has witnessed the Zacks Consensus Estimate for its current year earnings rising 2.8% over the last 60 days.
Libbey, Inc. Price and Consensus
Libbey, Inc. price-consensus-chart | Libbey, Inc. Quote
This Zacks Rank #2 (Buy) company has a dividend yield of 6.65%, compared with the industry average of 1.64%. Its five-year average dividend yield is 2.53%.
Libbey, Inc. Dividend Yield (TTM)
Libbey, Inc. dividend-yield-ttm | Libbey, Inc. Quote
Kohl's Corporation (KSS - Free Report) : This omni-channel retailer has witnessed the Zacks Consensus Estimate for its current year earnings advancing 0.6% over the last 60 days.
Kohl's Corporation Price and Consensus
Kohl's Corporation price-consensus-chart | Kohl's Corporation Quote
This Zacks Rank #2 (Buy) company has a dividend yield of 3.31%, compared with the industry average of 0.47%. Its five-year average dividend yield is 3.7%.
Kohl's Corporation Dividend Yield (TTM)
Kohl's Corporation dividend-yield-ttm | Kohl's Corporation Quote
Guess', Inc. (GES - Free Report) : This apparel company has witnessed the Zacks Consensus Estimate for its current year earnings rising 2% over the last 60 days.
Guess?, Inc. Price and Consensus
Guess?, Inc. price-consensus-chart | Guess?, Inc. Quote
This Zacks Rank #2 (Buy) company has a dividend yield of 3.94%, compared with the industry average of 0.00%. Its five-year average dividend yield is 4.8%.
Guess?, Inc. Dividend Yield (TTM)
Guess?, Inc. dividend-yield-ttm | Guess?, Inc. Quote
See the full list of top ranked stocks here.
Find more top income stocks with some of our great premium screens.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>